Free Trial

Clear Harbor Asset Management LLC Grows Position in UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Medical background

Key Points

  • Clear Harbor Asset Management LLC increased its stake in UnitedHealth Group by 54.0% during the second quarter, holding 13,785 shares valued at $4,301,000.
  • Despite missing earnings estimates, UnitedHealth Group reported revenue of $111.62 billion, reflecting a 12.9% year-over-year increase.
  • Analysts maintain a generally positive outlook with a consensus rating of "Moderate Buy" and an average target price of $358.95 for UnitedHealth shares.
  • Interested in UnitedHealth Group? Here are five stocks we like better.

Clear Harbor Asset Management LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 54.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,785 shares of the healthcare conglomerate's stock after buying an additional 4,833 shares during the quarter. Clear Harbor Asset Management LLC's holdings in UnitedHealth Group were worth $4,301,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in UNH. Brighton Jones LLC lifted its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. AlphaCore Capital LLC raised its holdings in shares of UnitedHealth Group by 6.8% during the fourth quarter. AlphaCore Capital LLC now owns 647 shares of the healthcare conglomerate's stock worth $327,000 after purchasing an additional 41 shares during the period. Vermillion Wealth Management Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $90,000. Finally, Aurdan Capital Management LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $9,780,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on UNH shares. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research note on Wednesday, August 6th. Sanford C. Bernstein upped their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Finally, Oppenheimer dropped their price objective on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $358.95.

Get Our Latest Research Report on UNH

UnitedHealth Group Stock Up 0.6%

Shares of NYSE UNH opened at $336.72 on Monday. The stock has a market cap of $304.96 billion, a PE ratio of 14.59, a PEG ratio of 2.20 and a beta of 0.44. The business has a fifty day moving average of $295.67 and a two-hundred day moving average of $363.56. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 High-Growth Stocks at the Heart of the AI Buildout
Robot Revolution: 3 Must-Know Plays for Investors
Fed Decision Day  — What Today’s Move Means for Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines